1. Stefan Sleijfer, Daniel den Hoed Cancer Center, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands; Jan Bogaerts, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Lillian L. Siu, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.